Compared to Estimates, Cognizant (CTSH) Q1 Earnings: A Look at Key Metrics
Werte in diesem Artikel
For the quarter ended March 2025, Cognizant (CTSH) reported revenue of $5.12 billion, up 7.5% over the same period last year. EPS came in at $1.23, compared to $1.12 in the year-ago quarter.The reported revenue represents a surprise of +0.95% over the Zacks Consensus Estimate of $5.07 billion. With the consensus EPS estimate being $1.19, the EPS surprise was +3.36%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Financial services: $1.46 billion versus the two-analyst average estimate of $1.43 billion. The reported number represents a year-over-year change of +5.6%. Revenue- Communications, Media and Technology: $804 million versus $833.33 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.7% change. Revenue- Products and Resources: $1.28 billion versus $1.27 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +12.8% change. Revenue- Health Sciences: $1.57 billion versus $1.55 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +11% change. View all Key Company Metrics for Cognizant here>>>Shares of Cognizant have returned -4.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cognizant und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Cognizant
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cognizant
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cognizant Corp.
Analysen zu Cognizant Corp.
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital | |
08.02.2018 | Cognizant Strong Buy | Needham & Company, LLC | |
08.11.2017 | Cognizant Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
10.01.2017 | Cognizant Technology Solutions Hold | Loop Capital | |
30.09.2016 | Cognizant Technology Solutions Hold | Argus Research Company | |
09.09.2016 | Cognizant Technology Solutions Neutral | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.03.2009 | Cognizant Technology underperform | Wachovia Securities, LLC | |
18.12.2006 | Update Cognizant Technology Solutions Corp.: Under | HSBC Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognizant Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen